ABOUT

Mission and goal

Mission

"Based on novel circular RNA platform technology, we develop next generation of therapeutic modality to treat cancers and autoimmune diseases"

Goal

Cancers

  • Develop cancer vaccines for tumor-associated antigens and neoantigens by using proprietary circular RNA technology
  • Develop 'Off-the-Shelf' CAR-NKT cell therapy using circular RNA therapeutics

Autoimmune Diseases

  • Develop 'Off-the Shelf' CAR-NKT cells using circular RNA therapeutics to treat autoimmune diseases